TOP 2301: Neoadjuvant Chemo for NSCLC

Clinical trial NCT06385262 · SUSPENDED

Trial details

NCT number: NCT06385262
Sponsor: Duke University
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2025-03-17
Primary completion: 2028-10-30
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.